Neonatal HIV early infant diagnosis (EID) versus standard of care EID – Long term Impact on inFant hEalth: a feasibility study of point-of care testing at birth versus at 4-8 weeks of age, on the uptake of ART and infant prophylaxis, and on rates of infant survival, morbidity and retention in care.
The LIFE Study is a cluster randomised cohort study conducted at public health maternities in Tanzania (Mbeya Region) and Mozambique (Sofala and Manica Provinces) evaluating the clinical impact of infant birth point-of-care test & treat procedures in HIV-infected neonates.